The time since last menstrual period is important as a clinical predictor for non-steroidal aromatase inhibitor-related arthralgia

Aromatase inhibitor therapy: toxicities and management strategies in the treatment of postmenopausal women with hormone-sensitive early breast cancer

(2011) Susan F. Dent et al.   BREAST CANCER RESEARCH AND TREATMENT

A prospective study of aromatase inhibitor-associated musculoskeletal symptoms and abnormalities on serial high-resolution wrist ultrasonography

(2010) N. Lynn Henry et al.   CANCER

Effect of a switch of aromatase inhibitors on musculoskeletal symptoms in postmenopausal women with hormone-receptor-positive breast cancer: the ATOLL (articular tolerance of letrozole) study

(2009) Karine Briot et al.   BREAST CANCER RESEARCH AND TREATMENT

Patterns and risk factors associated with aromatase inhibitor-related arthralgia among breast cancer survivors

(2009) Jun J. Mao et al.   CANCER

Aromatase Inhibitor–Associated Arthralgias

(2009) Rowan T. Chlebowski   JOURNAL OF CLINICAL ONCOLOGY

Sonographic and Electrodiagnostic Evaluations in Patients With Aromatase Inhibitor–Related Arthralgia

(2009) Omer Dizdar et al.   JOURNAL OF CLINICAL ONCOLOGY

Letrozole Therapy Alone or in Sequence with Tamoxifen in Women with Breast Cancer

(2009)   NEW ENGLAND JOURNAL OF MEDICINE

Getting a Grip on Aromatase Inhibitor–Associated Arthralgias

(2008) Dawn L. Hershman   JOURNAL OF CLINICAL ONCOLOGY

Prospective Study to Assess Short-Term Intra-Articular and Tenosynovial Changes in the Aromatase Inhibitor–Associated Arthralgia Syndrome

(2008) Leilani Morales et al.   JOURNAL OF CLINICAL ONCOLOGY

Role of oestrogen in the development of joint symptoms?

(2008) Ai Lyn Tan et al.   LANCET ONCOLOGY

Risk factors for joint symptoms in patients enrolled in the ATAC trial: a retrospective, exploratory analysis

(2008) Ivana Sestak et al.   LANCET ONCOLOGY